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NorA is the best studied efflux system of Staphylococcus aureus and therefore
frequently used as a model for investigating efflux-mediated resistance in this pathogen.
NorA activity is associated with resistance to fluoroquinolones, several antiseptics and
disinfectants and several reports have pointed out the role of efflux systems, including
NorA, as a first-line response to antimicrobials in S. aureus. Genetic diversity studies
of the gene norA have described three alleles; norAI, norAII and norAIII. However,
the epidemiology of these alleles and their impact on NorA activity remains unclear.
Additionally, increasing studies do not account for norA variability when establishing
relations between resistance phenotypes and norA presence or reported absence,
which actually corresponds, as we now demonstrate, to different norA alleles. In the
present study we assessed the variability of the norA gene present in the genome of over
1,000 S. aureus isolates, corresponding to 112 S. aureus strains with whole genome
sequences publicly available; 917 MRSA strains sourced from a London-based study
and nine MRSA isolates collected in a major Hospital in Lisbon, Portugal. Our analyses
show that norA is part of the core genome of S. aureus. It also suggests that occurrence
of norA variants reflects the population structure of this major pathogen. Overall, this
work highlights the ubiquitous nature of norA in S. aureus which must be taken into
account when studying the role played by this important determinant on S. aureus
resistance to antimicrobials.
Keywords: Staphylococcus aureus, norA, alleles, variability, efflux
INTRODUCTION
Staphylococcus aureus is one of the major human pathogens in the hospital and community
settings, causing a wide array of clinical manifestations, from mild skin infections to life-
threatening systemic infections (Chambers and DeLeo, 2009; Tong et al., 2015). Development
and acquisition of resistance to antibiotics and other antimicrobials is of paramount
importance in S. aureus, as exemplified by the common occurrence and dissemination of
strains displaying a phenotype of multidrug resistance (MDR), including methicillin-resistant
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Staphylococcus aureus (MRSA) strains (Chambers and DeLeo,
2009). MRSA are spread worldwide and are a public health threat,
ranked amongst the major nosocomial pathogens (Lee et al.,
2018; Tacconelli et al., 2018). MRSA epidemiology has revealed
the local or global dissemination of a few number of clones,
namely the lineages in clonal complexes CC1, CC5, CC8, CC22,
CC30, CC45, CC59, and CC80 (Lee et al., 2018).
In recent years, several studies have supported drug eﬄux as
a player in the emergence of resistance toward antibiotics and
other antimicrobials in S. aureus (DeMarco et al., 2007; Furi et al.,
2013; Kwak et al., 2013; Costa et al., 2015). Of particular interest
are multidrug eﬄux pumps (MDR EPs), which extrude a wide
range of chemically dissimilar antimicrobials, being frequently
associated with MDR phenotypes in bacteria (Piddock, 2006;
Poole, 2007). In S. aureus, more than twenty putative MDR EPs
are encoded in the chromosome (Schindler et al., 2015), of which
several have already been characterized (Costa et al., 2013b).
Among these, NorA is the most well studied, being frequently
used as a model for studying eﬄux-mediated resistance in this
pathogen.
NorA is a 388 aminoacid protein with 12 transmembrane
segments (TMS) that belongs to the Major Facilitator Superfamily
(MFS) of secondary transporters. This MDR EP uses the
proton motive force to extrude from the cell fluoroquinolones,
ethidium bromide, quaternary ammonium compounds, and
other antimicrobials (Yoshida et al., 1990; Kaatz et al., 1993;
Neyfakh et al., 1993). Several reports have associated NorA
activity to low-level resistance to fluoroquinolones and reduced
susceptibility to biocides (DeMarco et al., 2007; Huet et al.,
2008; Kosmidis et al., 2010; Costa et al., 2011, 2015; Furi et al.,
2013). Other studies support a broader substrate range for NorA,
including siderophores (Deng et al., 2012) and fusaric acid
(Marchi et al., 2015).
The NorA encoding gene, norA, was first identified in the
chromosome of a fluoroquinolone-resistant S. aureus isolate,
collected in 1986 at a Japanese hospital (Ubukata et al., 1989).
Early studies have shown that genetic diversity of this gene can
be captured by three alleles, differing up to 10% at the level of
the nucleotide sequence and 5% in the polypeptide sequence;
norAI (Yoshida et al., 1990), norAII (also described as norA23)
(Noguchi et al., 2004) and norAIII (also described as norA1199)
(Kaatz et al., 1993). The occurrence of norA variants is also
strengthened by a recent study by Brooks et al. (2018) that refers
to the variability of this gene in a set of over 150 S. aureus strains.
Although some studies have been conducted to ascertain the
impact of this genetic diversity on the eﬄux activity of NorA
(Schmitz et al., 1998; Sierra et al., 2000; Noguchi et al., 2004), this
effect remains unclear.
Despite this early characterization, there are still contradictory
reports in literature on the role of NorA in S. aureus eﬄux-
mediated antimicrobial resistance. Several studies have reported
on the putative absence of norA, most probably due to failure to
amplify this gene with primers directed to only one of the possible
norA alleles. The present study aims at clarifying some of these
aspects, by demonstrating that the norA gene is part of the core
genome of S. aureus, reflecting on the genetic variability of the
gene, its distribution amongst S. aureus clonal lineages, including
both methicillin-resistant and -susceptible strains and possible
impact on NorA function.
MATERIALS AND METHODS
Study Datasets
Four sets of nucleotide sequences of the norA structural gene and
the corresponding polypeptide sequences were used in this study,
comprising (i) the sequences of the three norA alleles described
to date in literature; (ii) the norA sequences from 112 S. aureus
whole genome sequences retrieved from the GenBank database;
(iii) the norA sequences from 917 MRSA strains sourced from
a London-based study (Auguet et al., 2018) (ENA accession
PRJEB11177); (iv) the norA sequences of nine MRSA isolates
collected in a major Hospital in Lisbon, Portugal, representative
of the circulating norA alleles in that hospital at the time (Costa
et al., 2011, 2016), which were deposited in GenBank.
A detailed list of all the sequences comprised in this study and
respective accession numbers can be found in Supplementary
Information S1. The Lisbon MRSA isolates were previously
characterized for their susceptibility toward fluoroquinolones
and biocides and presence of mutations in the quinolone-
resistance determining region of grlA/gyrA genes (Costa et al.,
2011, 2013a) – Supplementary Information S1. Information on
the remaining S. aureus strains was gathered from the GenBank
database and relevant published papers.
Whenever sequence types (ST) were not provided, in silico
MLST was performed using the MLST 1.8 (Larsen et al., 2012)
and SRST2 (Inouye et al., 2014) softwares. The datasets were
used to construct a pan-genome (set of all genes within a given
species), and a core genome (set of genes found in all strains of
that species) for S. aureus (Tettelin et al., 2005; van Tonder et al.,
2014).
Sequence Analysis of norA and MLST
Alleles
De novo assemblies were performed for all London samples
using Velvet (Zerbino and Birney, 2008) and VelvetOptimiser
(Zerbino, 2010). Resulting contig FASTA files and FASTA files of
the S. aureus samples obtained from GenBank were annotated
using Prokka (Seemann, 2014). The pan-genome of these samples
was then constructed with Roary (Page et al., 2015), and the
sequences of the norA and MLST genes (arcC, aroE, glpF, gmk,
pta, tpi, and yqiL) isolated using custom R scripts (R Core Team,
2016).
For the set of the nine Portuguese MRSA clinical isolates,
norA was amplified by PCR using three pairs of primers
(Table 1). PCR reaction mixtures were prepared in 0.05 mL
containing 2.5 U Taq Polymerase (Thermo Scientific, Waltham,
MA, United States); 1X Taq buffer (Thermo Scientific); 30 pmol
of each primer (Invitrogen, Carlsbad, CA, United States); 0.2 mM
dNTPs (GE Healthcare, Chicago, IL, United States); 1.75 mM
MgCl2 (Thermo Scientific). The amplification conditions were
the following: initial DNA denaturation step at 95◦C for 3 min,
followed by 35 cycles of denaturation at 94◦C for 1 min, annealing
at 52◦C [norA(a)], 45◦C [norA(b)] or 50◦C [norA(c)] for 1 min,
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TABLE 1 | Primers used to sequence the norA promoter and coding region of
Staphylococcus aureus clinical strains.
Primer Sequence
(5′ – 3′)
Amplicon
size
Locationa Reference
norA_fw(a) TGTTAAGTCTT
GGTCATCTGCA
761 706005–706026 Couto et al.,
2008
norA_rv(a) CCATAAATCCA
CCAATCCC
706765–706747 This studyb
norA_fw(b) TTCACCAAGCC
ATCAAAAAG
620 706671–706690 Sierra et al.,
2000
norA_rv(b) CTTGCCTTTCT
CCAGCAATA
707290–707271 Couto et al.,
2008
norA_fw(c) GGTCATTATTA
TATTCAGTTGTTG
419 707135–707158 Schmitz et al.,
1998
norA_rv(c) GTAAGAAAAAC
GATGCTAAT
707553–707534
aPosition of the primers in the genome of S. aureus DSM20231 (accession no.
CP011526.1). bThe primer was designed with the aid of the free software Primer3
(http://primer3.sourceforge.net/) and tested in silico (http://insilico.ehu.es/PCR/).
and extension at 72◦C for 1 min, followed by a final extension step
at 72◦C for 5 min. The PCR products were sequenced using the
same set of primers and the sequences analyzed and assembled to
make up the entire fragment using the software MAFFT v. 61 and
BioEdit v. 7.0.9.02.
The norA and MLST gene sequences from all four datasets
were aligned using custom R scripts. Samples that shared
identical norA and MLST sequences were grouped together and
representative sequences used for phylogenetic reconstruction.
Maximum-likelihood (ML) tree construction was performed
on the aligned norA and concatenated MLST gene sequences
separately using RAxML (Stamatakis, 2014) with a GTRGAMMA
evolutionary model. The resulting phylogenetic trees were
displayed and annotated using FigTree3.
Analysis of the Impact of norA Variability
on NorA Activity
The tridimensional structure of the NorA eﬄux pump
was predicted via the in silico platform PHYRE2 (Protein
Homology/analogY Recognition Engine v2.04) (Kelley et al.,
2015) based on the nucleotide sequences of the three norA
variants described in literature. A mutational analysis based on
the predicted tridimensional structure was conducted with the
Phyre2 Investigator tools, using the SuSPect algorithm (Yates
et al., 2014). This algorithm produces a table of scores from 0
to 100 according to predicted deleteriousness (0 = neutral to
100 = deleterious). A score of 50 is recommended as a cut-off
between neutral and deleterious variants, with extreme scores
being more confident predictions (Yates et al., 2014). In this
work, a score of ≥75 was used as cut-off value.
1mafft.cbrc.jp/alignment/software/
2https://bioedit.software.informer.com/
3http://tree.bio.ed.ac.uk/software/figtree/
4http://www.sbg.bio.ic.ac.uk/phyre2
RESULTS AND DISCUSSION
norA Is Part of the Core Genome of
S. aureus
Our study sought to establish if norA is part of the core genome
of S. aureus. This is a relevant question since a significant part
of the studies on eﬄux-mediated resistance in this pathogen
focus mainly on the activity of NorA and some studies have
reported the absence of the norA gene in several S. aureus strains
(Monecke and Enricht, 2005; Vali et al., 2008; Conceição et al.,
2015; Hasanvand et al., 2015; Liu et al., 2015; Ammar et al.,
2016; Taheri et al., 2016; Antiabong et al., 2017; Hassanzadeh
et al., 2017; Hadadi et al., 2018; Kernberger-Fischer et al., 2018).
This reported absence could be explained by the genetic diversity
FIGURE 1 | (A) The distribution of genes in the pan-genome of the London
and GenBank S. aureus isolates (n = 1029). A total of 5,489 genes were
identified with 1,551 (28.25%) genes found in more than 99% of strains. The
majority of genes (55.3%) were identified as ‘cloud’ genes, found only in a
small number of samples (<15%), demonstrating the diversity of the S. aureus
genome. (B) Rarefaction curves for total (red line) and core (blue line) genes
identified when increasing the sample size to reconstruct the pan-genome.
Random sampling of samples was conducted 100 times and the mean size of
the core genome and number of total genes [and standard deviation (dotted
lines)] is shown as the sample size is increased by 1 to the total sample size
(n = 1029). 90% of the total genes are identified after 514 samples (49.5% of
total samples), and there is a plateau in size of the core genome (±5% of the
final genome size) at sample 256 (24.9% of total samples). The rarefaction
curve confirms that the gene diversity of the strains has been adequately
captured with the number of samples included in the analysis.
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of the gene and a consequent primer failure during norA PCR
screening. To test if norA is part of the core genome of S. aureus,
we constructed the pan-genome from the 1029 S. aureus isolates
whole genome sequence datasets (112 GenBank; 917 London
S. aureus isolates). The core genome of S. aureus consists of 1551
genes (found in ≥99% of individuals with 95% BLAST identity;
Figure 1A) with the genome of each individual isolate containing
a median of 2196 genes (with a range of 1955 to 2469), marginally
lower than the number of genes found in S. aureus reference
strains (Li et al., 2011). Rarefaction curves were calculated and
determined that the number of samples used was adequate to
accurately reconstruct the pan-genome of the population; 90% of
the total gene diversity was present when considering just 49.5%
(514/1029) of the samples and there was a stabilization of the
core genome size after 24.9% (256/1029) of the total samples
(Figure 1B). The norA gene was found to be present in all London
and GenBank samples and thus is part of the core genome, with
each sample containing a single gene variant. Additionally, we
performed a Blastn search using as query the nucleotide sequence
of the norAI allele (GenBank accession no. D90119.1) against
all S. aureus genome sequences (complete, scaffold or contig
formats) deposited in GenBank5, corresponding to more than
8.000 (circa 8.150) sequences. All the Blastn searched sequences
retrieved hits with ≥90% identity to norAI allele. This result
supports the notion that norA is a S. aureus core gene, occurring
in all S. aureus genomes. The finding that norA is part of S. aureus
core genome and thus is present in all S. aureus strains, implies
that reporting the detection of this gene is not sufficient to make
a direct association with a particular resistance phenotype. To
make such a correlation, one must carry out expression analysis
of the norA gene as well as of other eﬄux pump genes, as it
has been shown that S. aureus strains can display different eﬄux
pump gene expression patterns (DeMarco et al., 2007; Kosmidis
et al., 2010, 2012), even under pressure of the same antimicrobial
(Huet et al., 2008; Costa et al., 2011, 2015).
Genetic Diversity of the norA Gene
One of the goals of this study was to determine the distribution
of the norA variants amongst the several S. aureus clonal
lineages. A phylogenetic analysis was performed with the three
5www.ncbi.nlm.nih.gov/genome/genomes/154
FIGURE 2 | Maximum likelihood phylogeny of the norA sequences analyzed in this study. Identical norA sequences among all samples used in this study have been
collapsed and represented by a single label, which denotes a representative ST/CC of that group. The number of sequences is denoted by the last number of the tip
label. Four major groups are found, clustering with the norA alleles described in literature, norAI (D90119.1), norAII (AB019536.1), norAIII (M97169.1), and the allelic
variant norA-CC59/121. The norAI associated group is the most diverse, including samples belonging to CC1, CC5, CC8, CC15, CC80, and a wide range of
sequence types. The norAII associated group contains samples belonging to clonal complexes CC22, CC30, CC36, and CC398. Major nodes supported with
bootstrap values above 75% are denoted with a star.
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norA alleles and norA nucleotide sequences retrieved from
complete S. aureus genomes available in GenBank and from the
Portuguese and London-based S. aureus collections (Figure 2).
As expected, a certain degree of genetic variability was revealed
by the maximum-likelihood tree obtained, despite this gene being
relatively conserved. Figure 3 shows the distribution of the
pairwise genetic distance within norA across the samples used
to construct the phylogenetic tree, with a maximum of 143 SNP
differences between samples (12.3% of the total gene length of
1164 bp).
A global analysis showed a clear correlation between
occurrence of norA alleles and specific S. aureus clonal lineages.
The norAI allele was mainly associated with genetic backgrounds
of the clonal complexes CC1, CC5, CC8, and CC80 or closely
related lineages. On the other hand, norAII and close variants
appear to be restricted to strains belonging to CC30, CC398, and
CC22 (Figure 2). The norAIII allele is only associated with the
S. aureus lineage CC45 and novel but related STs.
Among the sequences retrieved from GenBank, the norAI
allele is the most frequent (76 out of 112 strains) and the
norAII allele the second most frequent allele (21 out of 112
strains), whereas norAIII occurs in just two CC45 strains. We
also detected 13 more divergent variants, most closely related to
the norAI allele, that were associated with other lineages, such
as CC59 and CC121 (Figures 2, 3). Although these findings
may be biased as the dataset analyzed reflects the current
epidemiologically S. aureus relevant clones, with a frequency of
∼70% MRSA strains (78 out of 112 genomes), it clearly shows
that norAI and related variants are the most prevalent alleles
across lineages, as suggested by earlier studies (Schmitz et al.,
1998; Sierra et al., 2000; Noguchi et al., 2004). Interestingly, a
sample isolated in Brazil in 2010 (FCFHV36) carried a norAI
type variant of the norA gene that included a frameshift mutation
in codon 129. This mutation caused a premature stop codon at
codon number 147, resulting in potential pseudogenization of
norA in this isolate.
Regarding the London isolates, we found the norAII allele
to be the most common allele, identified in 671/917 samples,
due to the high number of CC22 strains in the study samples
(539/917). As with the GenBank samples, the norAIII allele
was the least common variant found in the London isolates,
with only the three CC45 and four novel ST strains carrying
closely related variants. The norAI allele was found in 220/917
strains consisting of the broadest range of lineages, comprising
21 different STs. Additionally, one ST22 sample possessed a norA
variant with a frameshift mutation at codon 365 that results in a
premature stop codon at codon number 367 and, again, possible
pseudogenization.
Nine MRSA isolates, representative of a collection of 53
S. aureus clinical isolates isolated at a major Portuguese
Hospital and previously characterized for eﬄux activity and
clonal lineage (Costa et al., 2011, 2013a, 2015, 2016) were
added to the study to ascertain their norA allele. The full
sequence of the norA gene was determined for these isolates
and compared with norA alleles from major clonal lineages
(Figure 4). Both the norAI and norAII alleles were found
amongst the Portuguese isolates and their distribution reflects
the findings for the other datasets analyzed. Eight isolates from
FIGURE 3 | Distribution of the pairwise SNP distance within norA sequences used in this study. The norA sequences include norAI (D90119.1), norAII (AB019536.1)
and norAIII (M97169.1), the nine Portuguese isolates, 112 complete assemblies from GenBank, and 75 representative sequences of London isolates. The figure is
annotated to show the pairwise SNP distance between isolates both within (blue) and between (red) each of the four major norA groups described in the main text:
norAI group, norAII group, norAIII group, and CC121/CC59 group.
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FIGURE 4 | Continued
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FIGURE 4 | Multiple alignment of norA sequences of the three norA alleles, from selected Portuguese MRSA clinical isolates (SM) and from strains of representative
clonal lineages. The MRSA strains displayed were selected to represent the main clones found, namely SM10 – CC5; SM3 – CC22; MW2 – CC1; Newman – CC8;
MRSA252 – CC30. The Shine-Dalgarno (SD) sequence is underlined in black. The shaded regions correspond to the putative TMS of NorA as suggested by Paulsen
et al. (1996). The aminoacid regions inside the boxes are relative to the conserved motifs described for MFS transporters with 12 TMS. The black residues shown
above the main polypeptide sequence represent the variations present in the various NorA polypeptide sequences relatively to the NorAI variant. The red residues
represent alterations found among the SM collection of Portuguese MRSA clinical isolates. The red boxes indicate the primers described in Table 2 for distinction of
norA alleles.
clonal lineages CC5, CC8, and CC88 carried norAI and a
single isolate from clonal lineage CC22 harboured the norAII
allele (Figure 4). Combining information on norA allele, clonal
lineage and previous characterization of these isolates (Costa
et al., 2011) showed no correlation between norA allele, norA
expression levels, eﬄux capacity, or antimicrobial resistance
levels (Supplementary Information S1).
A wet lab PCR-based strategic approach is proposed for
detection and differentiation of the several norA alleles occurring
in S. aureus. The norAI and norAII alleles can be easily
distinguished using two sets of specific primers (Table 2 and
Figure 4). To amplify and differentiate norAIII from the norA
allele associated with CC59/CC121, an approach consisting in
PCR amplification followed by restriction of the PCR product
with HindIII can be applied (Table 2 and Figure 4).
Impact of Genetic Variability on NorA
Function
A mutational analysis was performed in silico via the PHYRE2
platform to construct a NorA structural model, using the SuSPect
algorithm to predict the effect of each residue substitution on
TABLE 2 | List of primers proposed to amplify and differentiate the norA alleles by
conventional PCR.
Primer Sequence
(5′ – 3′)
Amplified
norA allele
Amplicon
size (nt)
Reference
norA_fw(b) TTCACCAAGC
CATCAAAAAG
all 704 Sierra et al.,
2000
NorA2 GCACATCAAA
TAACGCACCT
YonorA ATATTCAGTTGT
TGTCTTAATAT
norAI 230 Sierra et al.,
2000
NorA2 GCACATCAAA
TAACGCACCT
NorAII CTGTATTCTTT
ATATACATCG
norAII 391 This studya
NorA2 GCACATCAAAT
AACGCACCT
Sierra et al.,
2000
NorAIII GACCCTAAAA
AAGTTTCGAC
norAIII 526 This studya
NorA2 GCACATCAAATA
ACGCACCT
norA-
CC59/CC121
Sierra et al.,
2000
Plus HindIII restriction:
norAIII: 166 nt + 360 nt;
norA-CC59/121: no cut (526 nt)
aThe primers were designed with the aid of the free software Primer3
(http://primer3.sourceforge.net/). The primers and the HindIII restriction were
tested in silico (http://insilico.ehu.eus/) against several S. aureus genome
sequences of representative clonal lineages.
NorA function. This analysis is limited because of the lack of
available structural data for bacterial MFS pumps, mostly limited
to substrate-specific transporters. Nevertheless, the polypeptide
sequences encoded by the three norAI alleles were used to
predict a tri-dimensional structure of NorA. All three NorA
variants showed the highest identity with the putative MFS
transporter YajR of Escherichia coli (Jiang et al., 2013). A second
NorA in silico model, based on the structure of glycerol-3-
phosphate MFS transporter from E. coli, described by Bhaskar
et al. (2016) was taken into account for comparison purposes.
The SuSPect-derived mutational analysis revealed 42 residues
for which particular mutations could potentially impair NorA
activity (Supplementary Information S2). Of these, residues
Pro110, Pro158, Pro311, and Gly326 were particularly susceptible
to mutations.
Analysis of the polypeptide sequence corresponding to the
three norA variants revealed a total of 43 amino acid alterations.
Figure 5 summarizes these alterations, their location in NorA
and their distribution amongst S. aureus lineages. There was no
overlap between these alterations and the residues identified by
SuSPect. We also compared the S. aureus NorAI variant with
the NorA eﬄux pump encoded in the Staphylococcus epidermidis
ATCC 12228 chromosome, which presents the same substrate
profile (Costa et al., 2018; Supplementary Information S2). The
differences encountered between the two polypeptide sequences
correspond to residues that were not highlighted as pivotal
for the protein activity by SuSPect. These results suggest
conservation of NorA function in these two main staphylococcal
species.
One alteration, Gly147Ser located within putative TMS 5, may
affect NorA function (Figure 4). This alteration was detected
in all four strains belonging to ST105 (three of which are
of Portuguese origin) and in one of the strains belonging to
ST225 (Portuguese origin) (Supplementary Information S2),
but was absent from strains from other CC5 lineages, such
as ST5. Residue 147 is predicted to be located within the
conserved motif C (gxxxGPxiGGxl) (Paulsen et al., 1996)
on the TMS 5, facing a water-filled channel. This motif is
conserved among MFS drug-H+ antiporters and has been
implicated in the binding of the substrate, with the glycines
being essential for that function (Ginn et al., 2000; Tamura
et al., 2001). In fact, in a mutagenesis study in S. aureus
eﬄux pump TetA(K), also a 12-TMS member of the MFS
family, the mutation Gly147Ser was responsible for the loss
of 80% of the activity of that eﬄux pump (Ginn et al.,
2000). Although Tet transporters and NorA are distinct in
their substrate specificity, these pumps share abundance of
glycines in TMS 5, a trait that has been postulated to confer
conformational plasticity to EPs (Ginn et al., 2000). Thus, the
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FIGURE 5 | Multiple alignment of NorA polypeptide sequences derived from alleles norAI (Yoshida et al., 1990), norAII (Noguchi et al., 2004), and norAIII (Kaatz
et al., 1993) and from the norA alleles from selected S. aureus strains. The MRSA strains displayed were selected to represent the main S. aureus clonal lineages
found for the strains with genomes publicly available and for the Portuguese strains (SM10 – CC5; SM39 – CC88). Sequences are grouped according to the
respective norA allele (orange – norAI; green – norAII; blue - norAIII; yellow – norA-CC59/121). The lines correspond to the transmembrane segments (TMS) of NorA,
as predicted by Paulsen et al. (1996) (green), by the HMMTOP method as presented in Bhaskar et al. (2016) (red) and as predicted by the Phyre2-based NorA model
(purple). The aminoacid regions inside the boxes are relative to the conserved motifs described for MFS transporters with 12 TMS (Paulsen et al., 1996). The red box
corresponds to the amino acid substitution likely to affect NorA function.
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mutation Gly147Ser may have a deleterious effect on NorA
activity. Additional studies are necessary to fully ascertain the
impact of this alteration in the eﬄux capacity of NorA. The
same applies to the full understanding of possible correlations
between a given norA allele and corresponding NorA eﬄux
capacity, probably requiring carefully controlled genetic systems
because of overlapping substrates between many staphylococcal
multidrug eﬄux systems and the redundancy in their response to
antimicrobials (Costa et al., 2013b; Schindler and Kaatz, 2016).
CONCLUSION
In this study we provide evidence that the eﬄux pump gene
norA is part of core genome of S. aureus. This gene presents
some genetic variability which may impair its detection by
conventional laboratorial techniques, such as PCR, due to
potential primer mismatch. Strikingly, a correlation was observed
between the several norA alleles and specific S. aureus lineages,
suggesting that the occurrence of norA variants reflects the
population structure of this major pathogen.
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